/NTRA
Natera, Inc.
NTRA • NASDAQNTRA • NASDAQ • Healthcare
$203.03-1.94%-4.01
$203.03-1.94%(-4.01)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
100Bullish
Risk
52Moderate
Momentum
46Neutral
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
64.8%▲4.6pp
Revenue after COGS
Operating
-13.4%▼0.3pp
After operating expenses
Net
-9.0%▲2.2pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
-150.5
Price vs earnings
EV/EBITDA
-115.4
Enterprise value
FCF Yield
0.3%
Cash generation
Earnings Yield
-0.7%
Inverse of P/E
Capital Efficiency
-11
GoAI Quality ScorePoor
ROEReturn on Equity
-12.2%Weak
ROAReturn on Assets
-8.3%Weak
ROICReturn on Invested Capital
-11.1%Weak
Financial Health
Current RatioHealthy
3.39
Short-term solvency (>1.5)
Net Debt / EBITDAHigh
3.26x
Debt repayment capacity (<3x)
Income QualityWeak
-1.03
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.31B | $1.70B | $1.08B | $820.22M | $625.49M |
| Gross Profit | $1.50B | $1.02B | $492.74M | $363.97M | $307.07M |
| Gross Margin | 64.8% | 60.3% | 45.5% | 44.4% | 49.1% |
| Operating Income | -$309.91M | -$222.29M | -$446.25M | -$541.04M | -$468.17M |
| Net Income | -$208.16M | -$190.43M | -$434.80M | -$547.80M | -$471.72M |
| Net Margin | -9.0% | -11.2% | -40.2% | -66.8% | -75.4% |
| EPS | -$1.52 | -$1.53 | -$3.78 | -$5.57 | -$5.21 |
Average Price Target
$249.57▲ 22.9% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for Natera, Inc., the average price target is $249.57, with a high forecast of $285.00 and a low forecast of $172.00. The average price target represents a 22.9% increase from the current price of $203.03.
Highest
$285.00
Average
$249.57
Lowest
$172.00
Rating Distribution
Strong Buy
0
0%
Buy
25
93%
Hold
2
7%
Sell
0
0%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Baird● Maintain
Outperform
2026-02-27Evercore ISI Group● Maintain
Outperform
2026-02-27Wells Fargo● Maintain
Equal Weight
2026-02-27Guggenheim● Maintain
Buy
2026-01-05Canaccord Genuity● Maintain
Buy
2025-12-22Barclays● Maintain
Overweight
2025-12-15JP Morgan● Maintain
Overweight
2025-12-15Wells Fargo● Maintain
Equal Weight
2025-12-15Canaccord Genuity● Maintain
Buy
2025-12-08BTIG● Maintain
Buy
2025-12-05Earnings History & Surprises
BEAT RATE
61%
Last 18 quarters
AVG SURPRISE
+12.4%
EPS vs Estimate
BEATS / MISSES
11/6
1 met exactly
LATEST EPS
$0.35
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
+168.4%
$0.35 vs $-0.51
Q4 '25
-65.9%
$-0.64 vs $-0.39
Q3 '25
-20.2%
$-0.74 vs $-0.62
Q2 '25
+21.9%
$-0.50 vs $-0.64
Q1 '25
-7.6%
$-0.41 vs $-0.38
Q4 '24
+54.4%
$-0.26 vs $-0.57
Q3 '24
+56.5%
$-0.30 vs $-0.69
Q2 '24
+21.1%
$-0.56 vs $-0.71
Q1 '24
+12.3%
$-0.64 vs $-0.73
Q4 '23
+1.0%
$-0.95 vs $-0.96
Q3 '23
+11.0%
$-0.97 vs $-1.09
Q2 '23
-7.0%
$-1.23 vs $-1.15
No investor questions available.
Latest News
No news available